HK1201271A1 - Kinase inhibitor polymorphs - Google Patents

Kinase inhibitor polymorphs Download PDF

Info

Publication number
HK1201271A1
HK1201271A1 HK15101873.3A HK15101873A HK1201271A1 HK 1201271 A1 HK1201271 A1 HK 1201271A1 HK 15101873 A HK15101873 A HK 15101873A HK 1201271 A1 HK1201271 A1 HK 1201271A1
Authority
HK
Hong Kong
Prior art keywords
kinase inhibitor
polymorphs
activity
inhibitor polymorphs
chemical compounds
Prior art date
Application number
HK15101873.3A
Other languages
English (en)
Chinese (zh)
Inventor
Martin Michael
Peter Worrall Christopher
Del Rio Gancedo Susanna
Ren Pingda
Original Assignee
Intellikine, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intellikine, Llc filed Critical Intellikine, Llc
Publication of HK1201271A1 publication Critical patent/HK1201271A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15101873.3A 2011-11-11 2012-11-12 Kinase inhibitor polymorphs HK1201271A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161558962P 2011-11-11 2011-11-11
US61/558,962 2011-11-11
PCT/US2012/064729 WO2013071272A1 (en) 2011-11-11 2012-11-12 Kinase inhibitor polymorphs

Publications (1)

Publication Number Publication Date
HK1201271A1 true HK1201271A1 (en) 2015-08-28

Family

ID=48290672

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101873.3A HK1201271A1 (en) 2011-11-11 2012-11-12 Kinase inhibitor polymorphs

Country Status (5)

Country Link
US (1) US9403820B2 (enExample)
EP (1) EP2776428A4 (enExample)
JP (1) JP6078076B2 (enExample)
HK (1) HK1201271A1 (enExample)
WO (1) WO2013071272A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE512674T1 (de) 2003-01-06 2011-07-15 Angiochem Inc Angiopep-1, verwandte verbindungen, und deren verwnedungen
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
US8828925B2 (en) 2008-10-15 2014-09-09 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
RU2011146654A (ru) 2009-04-20 2013-05-27 Ангиокем Инк. Способы лечения рака яичников с применением конъюгированного средства
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
EP2792360A1 (en) 2013-04-18 2014-10-22 IP Gesellschaft für Management mbH (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
US20160287601A1 (en) * 2013-10-03 2016-10-06 Millennium Pharmaceuticals, Inc. Enhanced treatment regimens using pi3k inhibitors
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
JP2018039755A (ja) * 2016-09-08 2018-03-15 大塚化学株式会社 ナトリウム２α−メチル−２β−（１，２，３−トリアゾール−１−イル）−メチルペナム−３α−カルボン酸１，１−ジオキシド一水和物結晶の製造方法
CN115989022A (zh) * 2020-07-02 2023-04-18 阿瑟姆治疗株式会社 口服用药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE10050663A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
US7678799B2 (en) * 2003-06-03 2010-03-16 Teva Pharmaceutical Industries Ltd. Crystalline ziprasidone HCl and processes for preparation thereof
EP1591625A1 (en) * 2004-04-30 2005-11-02 ALSTOM Technology Ltd Gas turbine blade shroud
AU2006296386A1 (en) * 2005-09-30 2007-04-05 Astrazeneca Ab Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
BRPI0906473A8 (pt) 2008-01-04 2016-02-10 Intellikine Inc Certas entidades químicas, composições e métodos
US8193182B2 (en) * 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
UA111579C2 (uk) * 2009-08-17 2016-05-25 Інтеллікіне Ллк ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ

Also Published As

Publication number Publication date
US20150005301A1 (en) 2015-01-01
WO2013071272A1 (en) 2013-05-16
EP2776428A1 (en) 2014-09-17
JP2014533285A (ja) 2014-12-11
US9403820B2 (en) 2016-08-02
EP2776428A4 (en) 2015-04-22
JP6078076B2 (ja) 2017-02-08

Similar Documents

Publication Publication Date Title
ZA201401211B (en) Kinase inhibitor polymorphs
EP2723741B8 (en) Substituted imidazopyridinyl-aminopyridine compounds
EP2710018B8 (en) Macrocyclic compounds as protein kinase inhibitors
PL2710007T3 (pl) Inhibitory kinazy
ZA201404156B (en) Kinase inhibitors
IL228103A0 (en) Amino-quinolines as kinase inhibitors
IL229028A0 (en) Kinase inhibitors
EP2903618A4 (en) Rho kinase inhibitors
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
IL228967B (en) Heterocyclic compounds as kinase inhibitors
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
EP2776428A4 (en) KINASEHEMMERPOLYMORPHE
AP3597A (en) Imidazopyridazines as akt kinase inhibitors
ZA201404157B (en) Kinase inhibitors
AU2011100047A4 (en) Memoriade
AU2011100090A4 (en) Alcotagz
AU2011904448A0 (en) Compounds
HK1192543A (en) Serine/threonine kinase inhibitors
GB201009730D0 (en) Kinase inhibitor compounds
HK1194061A (en) Raf kinase inhibitors
HK1195057A (en) Protein kinase inhibitors
AU2012905703A0 (en) Polymorph
HK1187784A (en) Cathepsin c inhibitors
HK1193613A (en) Novel inhibitor compounds of phosphodiesterase type 10a